Program News and Updates

• Florida--Abbott v. Mylan Orange Book Case
  
  On June 22, 2009, the Court of Appeals of Florida issued a ruling that has significant implications for all states in which generic substitution laws defer to the FDA’s Orange Book as the standard for therapeutic equivalence evaluations. In Abbott Laboratories v. Mylan Pharmaceuticals, the court reversed the earlier ruling of an Administrative Law Judge.
  
  
• Biomedical & Pharmaceutical Careers?
  
  “If we can be successful at transferring knowledge from our academic institutions to
  the high achievers in the business world, Florida can become a third focus of national
  leadership in the biomedical and pharmaceutical industries.”
  
  
  
• UF & Stetson Announce New Business & Pharmacy Dual Master’s Degree
  
  
  
• Pharmacists – Liability for Medication Therapy Management
  A Washington state federal court rules that allegations of malpractice by a pharmacist in managing
  anticoagulation therapy will proceed to trial…